Daily versus alternate day oral iron supplementation for the treatment of iron deficiency anaemia in pregnancy (IronMother)

Conditions

Iron deficiency anaemia in pregnancy

Brief summary

Hb levels at 4 weeks post IMP treatment

Detailed description

Compliance as measured by objective pill count at 4 week assessment, Serum ferritin levels in both groups after 4 weeks treatment, Compliance as measured by questionnaire at 4 week assessment, Tolerance as measured by gastrointestinal symptom questionnaire at 4 week assessment, Obstetric and neonatal outcomes : o Delivery outcomes (livebirth, stillbirth, NND) o Mode of delivery (OVD, SVD, LSCS) o Rates and quantitation of primary PPH o Postnatal blood transfusion in the two weeks post-delivery (Y/N, if yes for RCC no. of units) o Postnatal iron transfusion in the two weeks post-delivery o Neonatal Intensive Care Unit admission (Y/N) o Apgar scores (at 1 and 5 minutes of life as standard) o Birth weights o Most recent Hb levels at term (37-42 wks gestation)

Related papers

No related papers found yet.

Interventions

DRUGGalfer 305mg Hard Capsules

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Hb levels at 4 weeks post IMP treatment	—

Secondary

Measure	Time frame
Compliance as measured by objective pill count at 4 week assessment, Serum ferritin levels in both groups after 4 weeks treatment, Compliance as measured by questionnaire at 4 week assessment, Tolerance as measured by gastrointestinal symptom questionnaire at 4 week assessment, Obstetric and neonatal outcomes : o Delivery outcomes (livebirth, stillbirth, NND) o Mode of delivery (OVD, SVD, LSCS) o Rates and quantitation of primary PPH o Postnatal blood transfusion in the two weeks post-delivery (Y/N, if yes for RCC no. of units) o Postnatal iron transfusion in the two weeks post-delivery o Neonatal Intensive Care Unit admission (Y/N) o Apgar scores (at 1 and 5 minutes of life as standard) o Birth weights o Most recent Hb levels at term (37-42 wks gestation)	—

Measure

Time frame

Compliance as measured by objective pill count at 4 week assessment, Serum ferritin levels in both groups after 4 weeks treatment, Compliance as measured by questionnaire at 4 week assessment, Tolerance as measured by gastrointestinal symptom questionnaire at 4 week assessment, Obstetric and neonatal outcomes : o Delivery outcomes (livebirth, stillbirth, NND) o Mode of delivery (OVD, SVD, LSCS) o Rates and quantitation of primary PPH o Postnatal blood transfusion in the two weeks post-delivery (Y/N, if yes for RCC no. of units) o Postnatal iron transfusion in the two weeks post-delivery o Neonatal Intensive Care Unit admission (Y/N) o Apgar scores (at 1 and 5 minutes of life as standard) o Birth weights o Most recent Hb levels at term (37-42 wks gestation)

—

Countries

Ireland

Outcome results

None listed